Santhera Pharmaceuticals Holding AG is a Swiss specialty pharmaceutical company that develops and markets medicines for rare diseases affecting the muscles, nerves and mitochondria. Its main product is idebenone, sold as Raxone, which is used to treat a hereditary form of vision loss. The company also works on treatments for neuromuscular conditions such as Duchenne muscular dystrophy. Santhera is based in Pratteln, Switzerland, and serves patients and clinicians in European and other markets through its own staff and partners.
The shares are listed on the London Exchange in UK under the code 0QN1, and the price on this page is in pounds sterling (GBP). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #2526 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
41/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-7.3%
From 52-week high-22.9%
MomentumWeak
48/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-6.6%
6-month return-18.8%
12-month, skipping last month53.1%
Stability (higher is calmer)Weak
43/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)50.2%
Worst drawdown, 1 year (smaller is calmer)-26.0%
LiquidityWeak
32/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.12M GBP
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 9.90 – 18.72Daily closes, split-adjusted
Signals
50-day average15.52
200-day average15.43
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.52
Technical summary
Daily
Strongly bearish
0 bullish · 4 neutral · 12 bearish
Weekly
Bearish
4 bullish · 1 neutral · 7 bearish
Monthly
Bullish
5 bullish · 1 neutral · 2 bearish
Moving averages (daily)
SMA 10
14.56
Bearish
EMA 10
14.52
Bearish
SMA 20
14.98
Bearish
EMA 20
14.84
Bearish
SMA 50
15.52
Bearish
EMA 50
15.23
Bearish
SMA 100
15.46
Bearish
EMA 100
15.37
Bearish
SMA 200
15.43
Bearish
EMA 200
15.06
Bearish
Oscillators (daily)
RSI (14)
42.61
Neutral
MACD (12, 26)
-0.37
Bearish
Momentum (12)
-7.32
Bearish
Stochastic %K (14)
33.47
Neutral
Williams %R (14)
-66.53
Neutral
CCI (20)
-79.97
Neutral
Pivot points (classic, last session)
S3
14.07
S2
14.16
S1
14.23
Pivot
14.32
R1
14.39
R2
14.48
R3
14.55
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in GBP. Educational only, not financial advice.
